Dr. Goldstein is Professor of Clinical Pharmacology in the Department of Bio-Medical Sciences at PCOM.
Dr. Goldstein's research interests have focused on use of drugs to reduce pain in postoperative patients (C-section; gall bladder removal) and medications combined with osteopathic manipulation in post-surgical hysterectomy patients. His other studies have included use of drugs to reduce cancer pain and for those with chronic pain. He currently conducts two investigations to increase analgesia in those with chronic neuropathic pain using THC or a THC-CBD combination.
In addition to his teaching and research at PCOM, he lectures in pharmacology at the University of Pennsylvania School of Dental Medicine. Dr. Goldstein also serves on the editorial board of, and reviews submissions for, the Journal of Opioid Management. He is an active member of the National Board of Osteopathic Medical Examiners where he writes and reviews questions for the COMLEX Level 1 test.
Dr. Goldstein's clinical interests have focused on pharmacologic methods to reduce pain in post-operative, cancer and hospice patients. He currently conducts research studies using THC or a THC-CBD combination to improve analgesia in patients presenting with chronic neuropathic pain.
Research keywords:
Lindback Award for Distinguished Teaching from the USP in 1990.
Dr. Goldstein's memberships include the Rho Chi Honor Society, Sigma Xi, American Society for Pharmacology and Experimental Therapeutics, American College of Clinical Pharmacology, American Pain Society, and International Association for the Study of Pain.
© 2026 Philadelphia College of Osteopathic Medicine
